AzTrials
AzTrials

Low Back PainNCT06890052

Effects of Isolated Lumbar Extension Resistance Training Alone and in Combination with General Exercise and Manual Therapy

A study testing Targeted exercise program and Targeted exercise as part of an integrative therapy program in people with Low Back Pain and Multifidus, run by University of Wuerzburg at 1 site in Germany.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study examines effects of machine-based isolated lumbar extension resistance exercise (ILEX) on paraspinal muscle morphology and function, as well as pain intensity, disability and quality of life in patients with chronic low back pain and radiculopathy related to specific spinal disorders. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Low Back Pain, Multifidus, Exercise Therapy
What is being tested?
Targeted exercise program and Targeted exercise as part of an integrative therapy program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteGermany
Study dates
1 Dec 2021to 24 Jun 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • chronic LBP for > 3 months, defined as pain in the region between the lower ribs and gluteal folds, with or without leg pain
  • seeking care in the facility of the study
  • doctoral assessment indicating symptoms related to disc herniations/protrusions and other specific conditions
  • moderate pain levels at the time of doctoral assessment

Who cannot join

  • acute low back pain (pain < 3 months)
  • familiarity with the device (usage within the previous 12 months)
  • fractures

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University of Wuerzburg, Institute of Sports Science

    Würzburg, Bavaria, 97072

Other trials in Germany

About this study

Official title: Effects of Isolated Lumbar Extension Resistance Exercise and the Impact of Additional Treatments on Multifidus Muscle Morphology, Strength, and Patient-Reported Outcomes in Chronic Low Back Pain and Radiculopathy Related to Spinal Disorders: a Closely-Monitored Clinical Trial

This study examines effects of machine-based isolated lumbar extension resistance exercise (ILEX) on paraspinal muscle morphology and function, as well as pain intensity, disability and quality of life in patients with chronic low back pain and radiculopathy related to specific spinal disorders. Current guidelines emphasize the necessity of treating chronic low back pain with integrative, holistic approaches due to its multidimensional nature. At the same time, an increasing number of studies highlight the importance of restoring lumbar muscle function and morphology through targeted training. Regarding ILEX, existing studies already support its clinical value, however, the optimal integration of ILEX with other therapeutic modalities remains unclear.

Two groups will be enrolled in an ILEX protocol (16 weeks, 25 sessions), while one of the groups will additionally participate in general exercise and manual therapy.

After completion of the main program, participants will be given different options to continue the exercise therapy with a reduced frequency (e.g., once per month). After six months, a follow-up assessment will be conducted with all participants to analyze long-term efficacy.

Being tested
Targeted exercise program, Targeted exercise as part of an integrative therapy program
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Targeted exercise programOther

    Participants in the active comparator group will perform 25 sessions of isolated lumbar extension resistance exercise (ILEX) using a new machine-based device equipped with a pelvic restraint system to ensure targeted conditioning of the paraspinal muscles. The exercise will be supplemented by visual biofeedback displayed on a computer screen. A detailed protocol will be followed, incorporating an individualized, diagnosis-based range of motion and progressive resistance overload. The supervised 16-week program consists of two sessions per week for the first nine weeks, followed by one session per week for the remaining seven weeks.

  • Targeted exercise as part of an integrative therapy programOther

    Participants in the experimental group will perform 25 sessions of isolated lumbar extension resistance exercise (ILEX) using a new machine-based device equipped with a pelvic restraint system to ensure targeted conditioning of the paraspinal muscles. The exercise will be supplemented by visual biofeedback displayed on a computer screen.

    A detailed protocol will be followed, incorporating an individualized, diagnosis-based range of motion and progressive resistance overload.

    The supervised 16-week program consists of two sessions per week for the first nine weeks, followed by one session per week for the remaining seven weeks.

    Each session is supplemented with general exercises for the back and trunk muscles (e.g., lat pulldown, abdominal crunch). In addition, participants will receive at least five sessions of therapy, which may include joint mobilization, tissue treatment, stress management, and other therapeutic modalities.

Study groups in NCT06890052
Study groupRoleWhat they receive
ILEX-OnlyActive comparatorA supervised 16-week program consisting of 25 sessions of isolated lumbar extension resistance exercise (ILEX) using a new machine-based device. The program includes two sessions per week for the first nine weeks, followed by one session per week for the remaining seven weeks.
Receives: Other: Targeted exercise program
ILEX supplemented with General Exercise and Manual TherapyExperimentalA supervised 16-week program consisting of 25 sessions of isolated lumbar extension resistance exercise (ILEX) using a new machine-based device. The program includes two sessions per week for the first nine weeks, followed by one session per week for the remaining seven weeks. Each session is supplemented with four general strengthening exercises. Additionally, patients receive manual therapy (MT).
Receives: Other: Targeted exercise as part of an integrative therapy program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Multifidus cross-sectional area (CSA; cm2)

    Multifidus muscle cross-sectional area measurements are obtained from ultrasound (US) from the L4/L5 spinal level (left and right)

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  2. Multifidus muscle thickness (MT; cm)

    Multifidus muscle thickness is measured with ultrasound (US) from the L4/L5 spinal level (left and right)

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  3. Multifidus echo intensity (EI; 0 -255 AU)

    Multifidus echo intensity (EI) is measured with ultrasound (US) from the cross-sectional area of the L4/L5 spinal level (left and right). EI is measured in arbitrary units (AU) via ImageJ on a scale from 0 (black) to 255 (white)

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

Secondary outcomes (11)
  1. Pain intensity (0-100)

    Pain intensity is measured with the visual analog scale (VAS) on a rating scale from 0 (no pain) to 100 (maximum pain).

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  2. Disability (0-50)

    Disability in relation to LBP is measured with the Oswestry Disability Index (ODI). It includes 10 items (e.g., sitting, standing, personal care) with a range from 0-6 with higher scores indicating greater disability.

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  3. Health-related quality of life (QoL; 0-100)

    Health-related quality of life (QoL) is measured with the short-form survey 345 (SF-36). The survey consists of 8 domains assessing physical and mental sum scores (PCS and MCS). Scores in each domain can range from 0 (zero health) to 100 (perfect health).

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  4. Isometric Lumbar Extensor Muscle Strength (Nm)

    Isometric lumbar extensor strength is measured with an isokinetic dynamometer as part of the Powerspine Back ILEX device. Measurements were taken at 39°, 30°, 24° and 15° in Newton meter (Nm).

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  5. Postural Alignment (°)

    Postural alignment will be measured with an infrared-based surface scanner (IDIAG M360). Included measures are angulations of 1) the thoracic spine, 2) the lumbar spine, and 3) the sacral inclination.

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  6. Mobility (°)

    Mobility is measured with an infrared-based surface scanner (IDIAG M360). Included measures are the mobility of the thoracic spine, the lumbar spine and the sacral inclination.

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  7. Stability (°)

    Stability is measured with an infrared-based surface scanner (IDIAG M360) and application of the Mathiass' Test. Included measures are angulations the thoracic spine, the lumbar spine, and the sacral inclination.

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  8. Muscle activity in sitting posture (mV)

    Sitting posture activity at the L4/L5 lumbar segment (bilateral) is measured using surface electromyography.

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  9. Muscle activity during static contraction in prone position (mV)

    Muscle activity during static contractin in prone position is measured at the L4/L5 level (bilateral) using surface electromyography.

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  10. Muscle activity during standing dynamic forward bend (mV)

    Muscle activity during during standing dynamic forward bend is measured at the L4/L5 level (bilateral) using surface electromyography.

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

  11. Heart rate variability (HR, RSA, RMSSD)

    Measures of heart rate variability are obtained including heart rate (beats/minute), respiratory sinus arrhytmia (RSA) and root mean square of successive differences (RMSSD).

    Measured: Baseline, 3-week, 6-week, 9-week, 16-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2025
  2. Study start1 Dec 2021
  3. Primary completion24 Dec 2024
  4. Study completion24 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06890052
Sponsor's protocol ID
01/2023
Status last verified
Mar 2025
First submitted
11 Mar 2025
Last updated
21 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Domokos B, Domokos J, Andersson G, Mannel S, Weigel LM, Koch HJ, Wallmann-Sperlich B, Raschka C, Spang C. Isolated lumbar extension exercise alone or in a multimodal program for low back pain and radiculopathy: a non-randomized controlled trial. Sci Rep. 2025 Oct 23;15(1):37157. doi: 10.1038/s41598-025-22452-x.

    PubMed 41131158

Questions about this trial

What is this clinical trial studying?

A study testing Targeted exercise program and Targeted exercise as part of an integrative therapy program in people with Low Back Pain and Multifidus, run by University of Wuerzburg at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 21 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Multifidus cross-sectional area (CSA; cm2) (time frame: Baseline, 3-week, 6-week, 9-week, 16-week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06890052, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in